We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Stance on Clinical Trial Reimbursements for Patient Travel, Lodging
FDA Clarifies Stance on Clinical Trial Reimbursements for Patient Travel, Lodging
The FDA updated its guidance to institutional review boards and clinical investigators, detailing its views on reimbursements for lodging and travel for clinical trial participants.